Jeffrey B. Landau, Chief Business Officer: CytomX Therapeutics CTMX Sell · Filed 23/12/22

Trade details

Type: Insider sale
Amount: $5,626.26
Shares · price: 4,077 sh · $1.38 a share
Held after: 86,622 sh
Stock: CytomX Therapeutics CTMX
Person: Jeffrey B. LandauChief Business Officer
Trade date: 23/12/20
Filed: 23/12/22
Days to filing: 2 days

Sold 4.5% of holdings

Share of holding sold: 4.5%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/20~24/01/19

Jeffrey B. Landau's recent trades

Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,143
4,181 sh
$5,143
Filed 24/08/22
Traded 24/08/20
Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$13.7K
6,562 sh
$13.7K
Filed 24/03/21
Traded 24/03/19
Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,355
4,119 sh
$5,355
Filed 23/09/22
Traded 23/09/22
Jeffrey B. LandauCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$2,924
1,477 sh
$2,924
Filed 23/03/20
Traded 23/03/16

Jeffrey B. Landau, Chief Officer — sold $5,626 of CytomX Therapeutics CTMX · 4.5% of holdings | Whalegun